Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: Prospective assessment with implications for enhancing compliance

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 8, Issue 3, 1996, Pages 261-270

  Singh, N ^a   Squier, C ^a   Sivek, C ^a   Wagener, M ^a   Hong Nguyen, M ^a   Yu, V L ^a,b  

^a VA Healthcare VISN 4   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CD4 ANTIGEN; ZIDOVUDINE;

ADULT; AGE; AGED; ANAMNESIS; ARTICLE; CLINICAL ARTICLE; COPING BEHAVIOR; DEMOGRAPHY; DEPRESSION; EDUCATION; EMOTIONAL STRESS; EMPLOYMENT; FITNESS; HEALTH STATUS; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LONGITUDINAL STUDY; MENTAL STRESS; MOOD; MORTALITY; MULTIVARIATE ANALYSIS; NEGRO; OPPORTUNISTIC INFECTION; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RACE DIFFERENCE; RELIGION;

EID: 0029994772     PISSN: 09540121     EISSN: None     Source Type: Journal    
DOI: 10.1080/09540129650125696     Document Type: Article

References (35)

1. ANDERSON, R.J. & KIRK, L.M. (1982). Methods of improving patient compliance in chronic disease states. Archives of Internal Medicine, 142, 1673-1675.
2. BECK A.T., WARD, C.H. & MENDELSON, M. (1961). An inventory for measuring depression. Archives of General Psychiatry, 6, 561-571.
3. BECKER, M.H. & MAIMAN, L.A. (1975). Sociobehavioral determinants of compliance with health and medical care recommendations. Medical Care, 12, 10-24.
4. BESCH, C.L., COLLINS, G., MORSE, E. & SIMON, P. (1992). Cofactors associated with participant compliance in two CPCRA trials. International Conference on AIDS, 8(3), 55 (Abstract No. Pu B7040).
5. BROERS, B., MORABIA, A. & HIRSCHEL, B. (1994). A cohort study of drug users' compliance with zidovudine treatment. Archives of Internal Medicine, 154, 1121-1127.
6. BURACK J.H., BARRETT, D.C., STALL, R.D., CHESNEY, M.A., EKSTRAND, M.L. & COATES, T.J. (1993). Depressive symptoms and CD4 lymphocyte decline among HIV-infected men. Journal of the American Medical Association, 270, 2568-2573.
7. CODY, J. & ROBINSON, A. (1977). The effect of low-cost maintenance medication on the rehospitalization of schizophrenic outpatients. American Journal of Psychiatry, 134, 73-76.
8. CORTESE, L., CHUNG, R., STOUTE, J., OSTER, C., MANSFIELD, J. & LEDSKY, R. (1993). Zidovudine usage: patient compliance and factors. International Conference on AIDS, 9(1), 507 (Abstract No. PO-332-2233).
9. EASTERBROOK, P.J., KERULY, J.C., CREAGH-KIRK, T., RICHMAN, D.D., CHAISSON, R.E. & MOORE, R.D.: THE ZIDOVUDINE EPIDEMIOLOGY STUDY GROUP (1991). Racial and ethnic differences in outcome in zidovudine treated patients with advanced HIV disease. Journal of the American Medical Association, 266, 2713-2718.
10. ERAKER, S.A., KIRSCHT, J.P. & BECKER, M.H. (1984). Understanding and improving compliance. Annals of Internal Medicine, 100, 258-268.
11. FAWZY, F.I., NAMIR, S., WOLCOTT, D.L., MITSUYASU, R.I. & GOTTLIEB, M.S. (1989a). The relationship between medical and psychological status in newly diagnosed gay men with AIDS. Psychiatric Medicine, 7, 23-33.
12. FAWZY, F.I., NAMIR, S. & WOLCOTT, D.L. (1989b). Structured group intervention model for AIDS patients. Psychiatric Medicine, 7, 35-45.
13. FORD, R. (1994, Jan./Feb.). The Skin I'm In. Plus Voice, the magazine about life and HIV, pp. 56-58.
14. GATLEY, M.S. (1968). To be taken as directed. Journal of Royal College of General Practice, 16, 39-44.
15. HAYNES, R.B. (1979). Determinants of compliance: the disease and the mechanics of treatment. In: R.B. HAYNES, D.W. TAYLOR & D.C. SACKETT (Eds). Compliance in health care (pp. 49-62). The Johns Hopkins University Press.
16. HOLLAND, J.C. & TROSS, S. (1985). The psychosocial and neuropsychiatrie sequelae of immunodeficiency syndrome and related disorders. Annals of Internal Medicine, 103, 765-767.
17. JACOBSEN, P.B., VASSALOS, C., BROWN, D., GORFINKLE, K., PHILOGENE, G. & POLSKY, B. (1989). Study compliance among asymptomatic HIV seropositive (ASX HIV +) being treated with azidothymidine (AZT). International Conference on AIDS 5, 407 (Abstract No. W.B. p. P352).
18. LIM, L., GRIMES, J., VOLBERDING, P., LAGAKOS, S., KROGSTAD, D. & SADLER, B. (1990). Compliance with study medication in a randomized trial of zidovudine (ACTG 019). International Conference on AIDS, 6(3), 285 (Abstract No. S.D. 783).
19. LIMA, J., NAZARIAN, L., CHARNEY, E. & LAHTI, C. (1976). Compliance with short-term antimicrobial therapy: some techniques that help. Pediatrics, 57, 383-386.
20. LOCAPUTO, S., MAGGI, P., BUCCOLIERO, G., FEDERICO, M., ANGARANO, G. & PASTORE, G. (1993). Antiretroviral therapy with zidovudine (AZT): evaluation of the compliance in a cohort of HIV positive patients. International Conference on AIDS, 9(1), 489 (Abstract No. PO-B26-2124).
21. LORR, M., DASTON, P. & SMITH, I.R. (1967). An analysis of mood states. Educational Psychology Measures, 27, 89-96.
22. MALAHEY, B. (1966). The effect of instructions and labeling in the number of medication errors made by patients at home. American Journal of Hospital Pharmacology, 23, 283-292.
23. MCNAIR, D.M., GOLDSTEIN, A.P., LORR, M., CIBELLI, L.A. & ROTH, I. (1965). Some effects of chlordiazepoxide and meprobamate with psychiatric outpatients. Psychopharmacologia, 7, 256-265.
24. MEICHENBAUM, D. & TURK, D.C. (1987). Treatment adherence: terminology, incidence, and conceptualization. In Facilitating treatment adherence (pp. 19-39). New York: Plenum.
25. MONANE, M., GURWITZ, J.H., MONANE, S. & AVORN, J. (1993, April). Compliance issues in medical practice. Hospital Physician, pp. 35-39.
26. MOORE, R.D., STANTON, D., GOPALAN, R. & CHAISSON, R.E. (1994). Racial differences in the use of drug therapy for HIV disease in an urban community. New England Journal of Medicine, 330, 763-768.
27. MUMA, R.D., ROSS, W.W., PARCEL, G.C. & POLLARD, R.B. (1995). Zidovudine adherence among individuals with HIV infection. AIDS Care, 7, 439-448.
28. NAMIR, S., WOLCOTT, D.L., FAWZY, F.I., ET AL. (1987). Coping with AIDS: psychological and health implications. Applied Social Psychiatry, 17, 309-328.
29. PERRY, S., FISHMAN, B., JACOBSBERG, L. & FRANCES, A. (1992). Relationship over one year between lymphocyte subsets and psychosocial variables among adults with infection by human immunodeficiency virus. Archives of General Psychiatry, 49, 396-401.
30. PORTER, A.M.W. (1969). Drug defaulting in general practice. British Medical Journal, 1, 218-222.
31. SAMET, J.H., LIBMAN, H., STEGER, K.A., DHAWAN, R., CHEN, J., SHEVITZ, A.H., DEWEES-DURK, R., LEVENSON, S., KUFE, D. & CRAVEN, D.E. (1992). Compliance with zidovudine therapy in patients infected with human immunodeficiency virus type I: a cross-sectional study in a municipal hospital clinic. American Journal of Medicine, 92, 495-502.
32. SOLOMON, G.F. (1989). Psychoneuroimmunology and human immunodeficiency virus infection. Psychiatric Medicine, 7, 47-57.
33. SOLOMON, G.F., TEMOSHOK, L., O'LEARY, A. & ZICH, J. (1989). An intensive psychoimmunologic study of long-surviving persons with AIDS. Annals of the New York Academy of Science, 496, 647-655.
34. VETTER, H., RAMSEY, L.E., LUSCHER, T.F., SCHREY, A. & VETTER, W. (1985). Symposium on compliance-improving strategies in hypertension. Journal of Hypertension, 35, 1-99.
35. WALL, T.L., SORENSON, J.L., LONDON, J., MORRIS, P., ABBOTT, C. & BATKI, S.L. (1992). Medication adherence in HIV infected injection drug users. International Conference on AIDS, 8(3), 145 (Abstract No. PuB7581).